Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Strata Critical Medical (SRTAW) EBT (2019 - 2025)

Historic EBT for Strata Critical Medical (SRTAW) over the last 7 years, with Q3 2025 value amounting to -$9.7 million.

  • Strata Critical Medical's EBT fell 7161.9% to -$9.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$35.7 million, marking a year-over-year increase of 3642.2%. This contributed to the annual value of -$27.6 million for FY2024, which is 5210.11% up from last year.
  • Strata Critical Medical's EBT amounted to -$9.7 million in Q3 2025, which was down 7161.9% from -$3.7 million recorded in Q2 2025.
  • Strata Critical Medical's EBT's 5-year high stood at $8.4 million during Q2 2022, with a 5-year trough of -$35.0 million in Q4 2023.
  • Over the past 5 years, Strata Critical Medical's median EBT value was -$9.2 million (recorded in 2022), while the average stood at -$8.6 million.
  • In the last 5 years, Strata Critical Medical's EBT crashed by 10252810.35% in 2021 and then soared by 20824.86% in 2022.
  • Strata Critical Medical's EBT (Quarter) stood at $663000.0 in 2021, then crashed by 2549.92% to -$16.2 million in 2022, then tumbled by 115.26% to -$35.0 million in 2023, then skyrocketed by 46.14% to -$18.8 million in 2024, then skyrocketed by 48.72% to -$9.7 million in 2025.
  • Its EBT was -$9.7 million in Q3 2025, compared to -$3.7 million in Q2 2025 and -$3.5 million in Q1 2025.